Talk:New Article Requests

Before You Submit a Proposal

• EVALUATION CRITERIA: Review these to be sure your proposal is eligible.
• EXISTING ARTICLES: Review these to see if your proposed topic is already included or could be inlcuded in an existing EyeWiki article. You can do this by performing a thorough search using various related key terms.
  • If you find a pre-existing stand-alone article that addresses your topic or an article that includes your topic please edit the article to include your own input. You will be automatically recognized as a contributor to that article.
  • Of those proposals that are not accepted, 85% are rejected because the topic is already covered or could be covered in an existing EyeWiki article.
• PROPOSALS PREVIOUSLY SUBMITTED: Review these and please do not resubmit these topics.

Instructions

• IMPORTANT: Review the section above "Before You Submit a Proposal"
• Click the "Add topic" link to create a new proposal on this page
• Then add the relevant list items as shown
  • Title: Enter this in the Subject field
  • Summary: Please provide some details about what will be covered and why you think the article would benefit EyeWiki. Do not submit a complete article.
  • Section: Indicate what subspecialty section the article should be added to. You may indicate up to 2 sections.
  • Submitted by: Name of the ophthalmologist submitting the proposal. Sign and date your request by entering 4 tilde ~ characters only. This will automatically add your username, a time stamp and a link to your profile. You will see this after you save the page.
    • SAMPLE: Rayna.Ungersma.AAO (talk) 10:01, April 30, 2024 (PDT)
• Click: SAVE at the bottom of the page

Sample Proposal

Biosimilars in Ophthalmology Summary: Patents for original biologics used to treat nAMD and DME are approaching expiration. Numerous companies are striving to replicate these biologics as biosimilars, which are drugs that mimic the effects of the original biologic, but do not have the same active ingredients. This article will summarize the current literature about biosimilars and their safety, efficacy, and quality and provide an in-depth review of approved biosimilars as well as those that are in development. This article will provide EyeWiki readers with information about numerous alternatives for treatment nAMD and DME.
Section: Retina/Vitreous
Submitted by: Rayna.Ungersma.AAO (talk) 15:04, May 1, 2024 (PDT)

Ocular Ehrlichiosis

Summary: Review of presentation and management of ocular ehrlichiosis Section: Uveitis Submitted by: Stephen.lau (talk) 07:09, October 9, 2024 (PDT)